Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Comparison of Whole Body DWI to FDG PET

NCT: NCT06630845 · RECRUITING

NCT IDNCT06630845
StatusRECRUITING
Start Date2025-02-06
Completion2029-10-31

Brief Summary

This is a single arm prospective trial that evaluates whole body diffusion weight imaging (DWI) compared to 18F-fludeoxyglucose (FDG) Positron Emission Tomography with Magnetic resonance imaging (PET/MRI) in participants with known metastatic cancer.

Frequently Asked Questions

What is Comparison of Whole Body DWI to FDG PET?

Comparison of Whole Body DWI to FDG PET is a clinical trial registered under NCT06630845. Current status: RECRUITING.

What is the status of NCT06630845?

The current status of NCT06630845 (Comparison of Whole Body DWI to FDG PET) is: RECRUITING.

When did Comparison of Whole Body DWI to FDG PET start?

Comparison of Whole Body DWI to FDG PET started on 2025-02-06.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.